Journal: Molecular and Clinical Oncology
Article Title: Correlation between salivary and serum CA15-3 concentrations in patients with breast cancer
doi: 10.3892/mco.2020.2062
Figure Lengend Snippet: Correlations of serum and salivary CA15-3. (A) Correlation curve of serum CA15-3 and salivary CA15-3 as detected by ELISA in patients with breast cancer (r=0.56; P=<0.01). (B) Correlation curve of serum CA15-3 and salivary CA15-3 as detected by CLIA in patients with breast cancer (r=0.36; P=0.19). (C) Correlation curve of serum CA15-3 and salivary CA15-3 as detected by ELISA in healthy controls (r=0.18; P=0.35). (D) Correlation curve of serum CA15-3 and salivary CA15-3 as detected by CLIA in healthy controls (r=0.08; P=0.77). ELISA, enzyme-linked immunosorbent assay; CLIA, chemiluminescence assay; CA15-3, cancer antigen 15-3.
Article Snippet: ELISA reactions were performed using the CA15-3 AccuBind ™ reagent kit (Lake Forest, California, United States of America) for use in BEST 2000 ® equipment (Biokit S.A.), according to the manufacturer's instructions.
Techniques: Enzyme-linked Immunosorbent Assay, Chemiluminescence Immunoassay